Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology

Volumn 55, Issue 8, 2010, Pages 823-834

  Agarwal, Shikhar ^a   Tuzcu, E Murat ^a   Desai, Milind Y ^a   Smedira, Nicholas ^a   Lever, Harry M ^a   Lytle, Bruce W ^a   Kapadia, Samir R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

hypertrophic cardiomyopathy; septal ablation; septal myectomy

Indexed keywords

ALCOHOL;

ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC PATIENT; CARDIOVASCULAR RISK; CATHETER ABLATION; CLINICAL EFFECTIVENESS; EXERCISE; FUNCTIONAL STATUS; GOLD STANDARD; HEART CONDUCTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART TAMPONADE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LENGTH OF STAY; LONG TERM CARE; MEDLINE; MITRAL VALVE REGURGITATION; MORTALITY; MUSCLE RESECTION; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETREATMENT; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ETHANOL; FEMALE; HEART SEPTUM; HUMANS; MALE; META-ANALYSIS AS TOPIC; TREATMENT OUTCOME;

EID: 76449100758     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.047     Document Type: Article

References (35)

1. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
2. Sigwart U. Catheter treatment for hypertrophic obstructive cardiomyopathy: for seniors only?. Circulation 118 (2008) 107-108
3. Smedira N.G., Lytle B.W., Lever H.M., et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 85 (2008) 127-133
4. Follmann D., Elliott P., Suh I., and Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45 (1992) 769-773
5. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. [updated September 2006]. In: The Cochrane Library, Issue 4, 2006.
6. Talreja D.R., Nishimura R.A., Edwards W.D., et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 44 (2004) 2329-2332
7. Sorajja P., Valeti U., Nishimura R.A., et al. Outcome of alcohol septal ablation for obstructive hypertrophic Cardiomyopathy. Circulation 118 (2008) 131-139
8. Nagueh S.F., Buergler J.M., Quinones M.A., Spencer III W.H., and Lawrie G.M. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 50 (2007) 795-798
9. Ralph-Edwards A., Woo A., McCrindle B.W., et al. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 129 (2005) 351-358
10. van der Lee C., ten Cate F.J., Geleijnse M.L., et al. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation 112 (2005) 482-488
11. Vural A.H., Tiryakioǧlu O., Türk T., et al. Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation. Heart Surg Forum 10 (2007) 493-497
12. Valeti U.S., Nishimura R.A., Holmes D.R., et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49 (2007) 350-357
13. Jiang T.Y., Wu X.S., Lu Q., Meng X., Jia C.Q., and Zhang Y. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy. Chin Med J (Engl) 117 (2004) 296-298
14. Qin J.X., Shiota T., Lever H.M., et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38 (2001) 1994-2000
15. Qin J.X., Shiota T., Lever H.M., et al. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 93 (2004) 171-175
16. Kwon D.H., Kapadia S.R., Tuzcu E.M., et al. Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. J Am Coll Cardiol Intv 1 (2008) 432-438
17. Firoozi S., Elliott P.M., Sharma S., et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 23 (2002) 1617-1624
18. Alam M., Dokainish H., and Lakkis N.M. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis. Eur Heart J 30 (2009) 1080-1087
19. Faber L., Seggewiss H., Gietzen F.H., et al. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol 94 (2005) 516-523
20. Maron B.J. Hypertrophic cardiomyopathy. JAMA 287 (2002) 1308-1320
21. Lever H.M. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation. Anadolu Kardiyol Derg 6 Suppl 2 (2006) 27-30
22. Fernandes V.L., Nagueh S.F., Wang W., Roberts R., and Spencer III W.H. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy-the Baylor experience (1996-2002). Clin Cardiol 28 (2005) 124-130
23. Serber E.R., Sears S.F., Nielsen C.D., Spencer III W.H., and Smith K.M. Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. Am J Cardiol 100 (2007) 1592-1597
24. Kwon D.H., Setser R.M., Thamilarasan M., et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart 94 (2008) 1295-1301
25. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
26. Yoerger D.M., Picard M.H., Palacios I.F., Vlahakes G.J., Lowry P.A., and Fifer M.A. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 97 (2006) 1511-1514
27. Maron M.S., Olivotto I., Zenovich A.G., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006) 2332-2339
28. Lakkis N.M., Nagueh S.F., Dunn J.K., Killip D., and Spencer III W.H. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol 36 (2000) 852-855
29. Kern M.J., Holmes D.G., Simpson C., Bitar S.R., and Rajjoub H. Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv 56 (2002) 503-507
30. Durand E., Mousseaux E., Coste P., et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J 29 (2008) 348-355
31. Seggewiss H., Rigopoulos A., Welge D., Ziemssen P., and Faber L. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 96 (2007) 856-863
32. Cuoco F.A., Spencer III W.H., Fernandes V.L., et al. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol 52 (2008) 1718-1723
33. Grigg L.E., Wigle E.D., Williams W.G., Daniel L.B., and Rakowski H. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. J Am Coll Cardiol 20 (1992) 42-52
34. Lawrenz T., Lieder F., Bartelsmeier M., et al. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49 (2007) 2356-2363
35. Olivotto I., Ommen S.R., Maron M.S., Cecchi F., and Maron B.J. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?. J Am Coll Cardiol 50 (2007) 831-834